ANGELA WHITE: Open Payments
NPI 1255611083 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 88 payments from 19 companies in 2025. Trend: 2023 $1,444 · 2024 $1,845 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $240 |
| AstraZeneca Pharmaceuticals LP | 7 | $207 |
| Novo Nordisk Inc | 12 | $195 |
| PFIZER INC. | 11 | $191 |
| Lilly USA, LLC | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $80 |
| Aimmune Therapeutics, Inc. | 3 | $51 |
| Exact Sciences Corporation | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
Products named: BREZTRI, NURTEC ODT, REXULTI, UBRELVY, Wegovy, VRAYLAR, CAPLYTA, MOUNJARO.
Industry payments across MI — which companies pay providers there.
